investorscraft@gmail.com

Intrinsic ValueOrege S.A. (OREGE.PA)

Previous Close0.27
Intrinsic Value
Upside potential
Previous Close
0.27

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Orege SA operates in the waste management sector, specializing in advanced sludge and effluent treatment solutions. The company's core revenue model is built on its patented SLG technology, which optimizes sludge conditioning, and its Le SLG-F system, integrating separation and thickening processes. Orege serves municipal and industrial clients across France, the U.S., Canada, Germany, and the U.K., offering not only equipment but also value-added services like maintenance, training, and process optimization. As a subsidiary of Eren Groupe SA, Orege leverages its niche expertise in sustainable waste treatment, positioning itself as a technology-driven player in an industry increasingly focused on environmental compliance and efficiency. The company’s solutions address critical challenges in sludge dewatering and effluent management, differentiating it from conventional waste treatment providers. Despite its specialized focus, Orege competes in a fragmented market where scale and technological edge are key determinants of success.

Revenue Profitability And Efficiency

Orege reported revenue of €3.0 million for the period, reflecting its niche market focus. However, the company posted a net loss of €8.5 million, underscoring ongoing challenges in achieving profitability. Operating cash flow was negative at €6.3 million, while capital expenditures remained modest at €0.4 million, indicating limited near-term growth investments.

Earnings Power And Capital Efficiency

The company’s diluted EPS of -€0.17 highlights its current lack of earnings power. With negative operating cash flow and high R&D or operational costs likely weighing on margins, capital efficiency appears strained. Orege’s ability to scale its technology and services will be critical to improving returns.

Balance Sheet And Financial Health

Orege’s financial health is pressured, with €0.6 million in cash against €46.8 million in total debt, signaling significant leverage. The limited liquidity and high debt burden raise concerns about near-term solvency, particularly as operating losses persist. The balance sheet may require restructuring or additional funding to sustain operations.

Growth Trends And Dividend Policy

Growth prospects hinge on broader adoption of Orege’s sludge treatment technology, though current financials show limited traction. The company does not pay dividends, reinvesting—or conserving—cash to support its operations. Expansion into new markets or applications could drive future revenue, but execution risks remain high.

Valuation And Market Expectations

With a market cap of €12.9 million, Orege trades at a low revenue multiple, reflecting skepticism about its path to profitability. The beta of 1.33 suggests higher volatility, aligning with its speculative profile. Investors likely await clearer signs of commercial scalability before assigning higher valuation premiums.

Strategic Advantages And Outlook

Orege’s proprietary SLG technology provides a competitive edge in sludge treatment, but commercialization challenges persist. The outlook depends on securing broader client adoption and improving financial sustainability. Strategic partnerships or additional funding could bolster its position, though the current high debt load remains a critical risk.

Sources

Company filings, Euronext Paris disclosures

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount